<DOC>
	<DOC>NCT02012036</DOC>
	<brief_summary>The purpose of the study is to assess additional detection of Non-Muscle-Invasive Bladder Cancer (NMIBC) with hexyl aminolevulinate (HAL) cystoscopy based on lesions in patients undergoing TUR-B compared to white-light cystoscopy under the conditions of daily clinical practice.</brief_summary>
	<brief_title>Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice</brief_title>
	<detailed_description />
	<criteria>Indication of TURB due to suspicion of NMIBC (patients suspected to have non muscle invasive bladder cancer). Subject able to comply with the protocol. Written informed consent available. Hypersensitivity to the active substance or to any of the excipients of the solvent. Porphyria. Gross haematuria. Women of childbearing potential. Repeated TURB (control TURB) as part of followup after previous TURB. Bacillus CalmetteGuerin (BCG) or Mitomycin / intravesical chemotherapy instillation therapy in the last 12 weeks or any other contraindications according to the SmPC. Subjects not able to give informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>